Skip to content
Clever SleepClever Sleep
  • Home
  • About Us
    • Sustainability Focus
    • Contact Us
  • My Dashboard
  • Practitioner login/register
  • Patient login/register
  • Cart

    No products in the cart.

    Clear Cart

Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem -V45I3

Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem -V45I3
Download
Objective sleep profile in LGI1/CASPR2 autoimmunity -V45I2
Temporal relationships between device-derived sedentary behavior, physical activity, and sleep in early childhood -V45I4

For more information on the CleverSleep® range, contact our specialist team at support@cleversleep.co.nz or call 0800 345 999

Copyright 2025 © CleverSleep®
  • Home
  • About Us
    • Sustainability Focus
    • Contact Us
  • My Dashboard
  • Login